F-star Therapeutics Inc

NASDAQ:FSTX   3:59:51 PM EDT
2.54
-0.20 (-7.30%)
Earnings Announcements

F-Star Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/10/2022 12:27 GMT
F-star Therapeutics Inc (FSTX) - F-star Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Qtrly Loss per Share $0.57.
Q1 Earnings per Share View $-0.67 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.08 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $1.06 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.